Correspondence 0001493152-24-044099 from JUPITER NEUROSCIENCES, INC. (JUNS)
JUPITER NEUROSCIENCES, INC.
Date: Nov. 7, 2024 · CIK: 0001679628 · Accession: 0001493152-24-044099
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-260183
Letter
VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences Attention: Daniel Crawford Re: Jupiter Neurosciences, Inc. Registration Statement on Form S-1 CIK No. 0001679628 File No. 333-260183
Dear Mr. Crawford and Ms. Hayes:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Jupiter Neurosciences, Inc. (the “Company”) respectfully requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) and declare such Registration Statement effective at 5:00 p.m., Eastern Time, on Friday, November 8, 2024, or as soon thereafter as practicable.
Under separate cover, you will receive today a letter from the representative of the underwriters of the proposed offering joining in the Company’s request for acceleration of the effectiveness of the Registration Statement.
It would be appreciated if, as soon as the Registration Statement is declared effective, you would so inform Craig D. Linder, Esq. of Anthony, Linder & Cacomanolis, PLLC at (561) 514-0936.
* * * *
Very
Truly Yours,
Jupiter
Neurosciences, Inc.
Show Raw Text
CORRESP
1
filename1.htm
Jupiter
Neurosciences, Inc.
1001
North US HWY 1, Suite 504
Jupiter,
Florida 33477
November
7, 2024
VIA
EDGAR
United
States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attention:
Daniel
Crawford
Suzanne
Hayes
Re:
Jupiter
Neurosciences, Inc.
Registration
Statement on Form S-1
CIK
No. 0001679628
File
No. 333-260183
Dear
Mr. Crawford and Ms. Hayes:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Jupiter Neurosciences, Inc. (the “Company”)
respectfully requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement
on Form S-1 (the “Registration Statement”) and declare such Registration Statement effective at 5:00 p.m., Eastern Time,
on Friday, November 8, 2024, or as soon thereafter as practicable.
Under
separate cover, you will receive today a letter from the representative of the underwriters of the proposed offering joining in the
Company’s request for acceleration of the effectiveness of the Registration Statement.
It
would be appreciated if, as soon as the Registration Statement is declared effective, you would so inform Craig D. Linder, Esq. of Anthony,
Linder & Cacomanolis, PLLC at (561) 514-0936.
*
* * *
Very
Truly Yours,
Jupiter
Neurosciences, Inc.
/s/
Christer Rosén
Christer
Rosén
Chief
Executive Officer
cc:
Craig D. Linder, Esq.